{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:54:17Z","timestamp":1791575657078,"version":"4.3.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003197","name":"Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.transci.2026.104539","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:45:50Z","timestamp":1790783150000},"page":"104539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["From delayed recognition to long-term disease control: Eltrombopag in severe MYH9-related disease"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4589-7462","authenticated-orcid":false,"given":"Miriana Carmela","family":"Limoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Santuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0868-5676","authenticated-orcid":false,"given":"Uros","family":"Markovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Raimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2026.104539_bib1","series-title":"GeneReviews\u00ae.","article-title":"MYH9-related disease","author":"Savoia","year":"2021"},{"key":"10.1016\/j.transci.2026.104539_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/01.md.0000076006.64510.5c","article-title":"MYH9-related disease: may-hegglin anomaly, sebastian syndrome, fechtner syndrome, and epstein syndrome are not distinct entities but represent a variable expression of a single illness","volume":"82","author":"Seri","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.transci.2026.104539_bib3","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3324\/haematol.2022.280856","article-title":"Treatment of inherited thrombocytopenias","volume":"107","author":"Balduini","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2026.104539_bib4","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1182\/blood-2010-08-304725","article-title":"Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations","volume":"116","author":"Pecci","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.transci.2026.104539_bib5","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3324\/haematol.2019.223966","article-title":"Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial","volume":"105","author":"Zaninetti","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2026.104539_bib6","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood-2017-04-748707","article-title":"Safety and efficacy of long-term treatment of chronic\/persistent ITP with eltrombopag: final results of the EXTEND study","volume":"130","author":"Wong","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.transci.2026.104539_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/humu.22476","article-title":"MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations","volume":"35","author":"Pecci","year":"2014","journal-title":"Hum Mutat"},{"key":"10.1016\/j.transci.2026.104539_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1160\/TH09-01-0068","article-title":"Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation","volume":"102","author":"Pecci","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.transci.2026.104539_bib9","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.1002\/ajh.25500","article-title":"Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia","volume":"94","author":"Zaninetti","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.transci.2026.104539_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31534","article-title":"Successful use of TPO-receptor agonist eltrombopag to correct thrombocytopenia for unrelated-donor renal transplant in an adolescent with MYH9-related disease","volume":"72","author":"Carter","year":"2025","journal-title":"Pediatr Blood Cancer"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226001710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226001710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:42:41Z","timestamp":1791574961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050226001710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1473050226001710"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2026.104539","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From delayed recognition to long-term disease control: Eltrombopag in severe MYH9-related disease","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2026.104539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104539"}}